News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biogen Idec, Inc. (Massachusetts) (BIIB), Elan Corporation PLC (ELN) (JOBS) MS Drug Improves Function Over 2 Years


9/22/2008 6:46:21 AM

LONDON, Sept 22 (Reuters) - Irish drugmaker Elan Corp Plc and U.S. partner Biogen Idec Inc said on Monday their Tysabri drug not only slows the progress of multiple sclerosis but, unlike other treatments, also leads to improvements in the condition of patients after two years.

Read at Reuters

Related News

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES